Opportunity Information: Apply for PAR 21 338
This funding opportunity (PAR 21-338) is a National Institutes of Health (NIH) discretionary grant administered through the National Center for Advancing Translational Sciences (NCATS). It supports Ruth L. Kirschstein National Research Service Award (NRSA) institutional postdoctoral training grants under the Clinical and Translational Science Awards (CTSA) Program using the T32 mechanism, with the important restriction that clinical trials are not allowed. The overall purpose is to strengthen structured postdoctoral research training for individuals who already hold health professional degrees, building a workforce of clinical and translational scientists who can move research discoveries toward real-world impact in areas like diagnostics, therapeutics, clinical interventions, and behavior change strategies that improve health outcomes.
The program is designed to enhance the quality and reach of postdoctoral training environments at eligible institutions, with an explicit emphasis on ensuring a heterogenous pool of trainees. In practice, this means the training program should be positioned to recruit, support, and prepare a diverse range of postdoctoral researchers and clinician-scientists for careers in clinical and translational science. The expected training focus is on developing the knowledge, skills, and abilities needed to conduct high-quality translational research, including the kinds of cross-disciplinary competencies that help trainees work across basic research, clinical research, and implementation into practice. Because the announcement specifies "Clinical Trial Not Allowed," applicant institutions should frame training plans and trainee research experiences around translational science activities that do not meet the NIH definition of a clinical trial.
Eligibility is broad across many types of U.S.-based organizations and government entities, reflecting the workforce and infrastructure goals of the CTSA ecosystem. Eligible applicants include state, county, city or township governments, and special district governments, as well as independent school districts. Eligible academic applicants include public and state-controlled institutions of higher education and private institutions of higher education. The opportunity is also open to federally recognized Native American tribal governments and Native American tribal organizations that are not federally recognized tribal governments. Additional eligible organizational types include public housing authorities/Indian housing authorities, nonprofits with or without 501(c)(3) IRS status (when not institutions of higher education), and for-profit organizations other than small businesses as well as small businesses. The announcement also calls out specific categories of institutions and organizations as eligible, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible agencies of the federal government, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and Indian/Native American tribal governments that are not federally recognized.
At the same time, there are clear limits on foreign participation. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. In other words, the applicant organization must be domestic, and the grant-supported institutional training activities must not be run through a foreign component. The funding activity category is Health, and the listed CFDA (now commonly referenced as Assistance Listing) number is 93.350. The opportunity was created on 2021-09-22, and the original closing date provided is 2024-09-13. The source data provided does not specify an award ceiling or the expected number of awards, so applicants would need to consult the full Funding Opportunity Announcement for budget structure details, award limits if any, and program-specific expectations for trainee slots, training duration, and allowable costs under the NRSA T32 mechanism.
Taken together, this opportunity is best understood as a targeted, limited-competition CTSA-aligned T32 program intended to build institutional capacity for high-quality postdoctoral training in clinical and translational science. It supports institutions in creating or strengthening structured training programs that prepare postdoctoral trainees with health professional backgrounds for translational research careers, while prioritizing broad participation and workforce heterogeneity, and while staying within the boundary that supported activities cannot include clinical trials.Apply for PAR 21 338
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.350.
- This funding opportunity was created on 2021-09-22.
- Applicants must submit their applications by 2024-09-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH NCATS CTSA NRSA T32 Institutional Postdoctoral Training (PAR 21-338)
What is PAR 21-338?
PAR 21-338 is a National Institutes of Health (NIH) discretionary funding opportunity administered by the National Center for Advancing Translational Sciences (NCATS). It supports Ruth L. Kirschstein National Research Service Award (NRSA) institutional postdoctoral training grants through the Clinical and Translational Science Awards (CTSA) Program using the T32 mechanism, with the restriction that clinical trials are not allowed.
Which NIH institute or center administers this opportunity?
This opportunity is administered through NIH by the National Center for Advancing Translational Sciences (NCATS).
What type of grant mechanism is used?
The opportunity uses the NRSA institutional training grant mechanism, T32, for postdoctoral research training aligned with the CTSA Program.
What is the main purpose of this training program?
The purpose is to strengthen structured postdoctoral research training for individuals who already hold health professional degrees, building a workforce of clinical and translational scientists who can move discoveries toward real-world impact (for example in diagnostics, therapeutics, clinical interventions, and behavior change strategies that improve health outcomes).
Who is the training intended to support (trainee focus)?
The program is intended to support postdoctoral research training for individuals who already hold health professional degrees, preparing them for careers as clinical and translational scientists.
What research or career areas does the program emphasize?
The emphasis is on clinical and translational science, including skills to move research discoveries toward real-world impact across areas such as diagnostics, therapeutics, clinical interventions, and behavior change strategies aimed at improving health outcomes.
Are clinical trials allowed under this opportunity?
No. The announcement specifies "Clinical Trial Not Allowed." Applicant institutions must frame training plans and trainee research experiences around translational science activities that do not meet the NIH definition of a clinical trial.
How should applicants handle the "Clinical Trial Not Allowed" restriction in the training plan?
Training plans and trainee research experiences should be designed around translational science activities that do not meet the NIH definition of a clinical trial. The opportunity explicitly notes that applicants should stay within this boundary when describing research experiences and program activities.
What is meant by strengthening the postdoctoral training environment?
Based on the information provided, the opportunity is intended to enhance the quality and reach of postdoctoral training environments at eligible institutions through structured training that builds translational research knowledge, skills, and abilities and supports cross-disciplinary competencies.
Does the program emphasize diversity or broad participation among trainees?
Yes. The opportunity includes an explicit emphasis on ensuring a heterogenous pool of trainees. In practice, the program should be positioned to recruit, support, and prepare a diverse range of postdoctoral researchers and clinician-scientists for careers in clinical and translational science.
What kinds of competencies are expected to be developed through the training?
The expected focus includes developing the knowledge, skills, and abilities needed to conduct high-quality translational research, including cross-disciplinary competencies that help trainees work across basic research, clinical research, and implementation into practice.
What is the overall program context (CTSA alignment)?
This is a CTSA-aligned T32 institutional training opportunity designed to build institutional capacity for postdoctoral training in clinical and translational science within the CTSA ecosystem.
What types of organizations are eligible to apply?
Eligibility is broad across many types of U.S.-based organizations and government entities. Eligible applicants include (as described in the opportunity):
- State, county, city, or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Native American tribal organizations that are not federally recognized tribal governments
- Public housing authorities/Indian housing authorities
- Nonprofits with or without 501(c)(3) IRS status (when not institutions of higher education)
- For-profit organizations other than small businesses
- Small businesses
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISI)
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Eligible agencies of the federal government
- Faith-based or community-based organizations
- Regional organizations
- U.S. territories or possessions
- Indian/Native American tribal governments that are not federally recognized
Can a foreign (non-U.S.) institution apply?
No. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply.
Can a U.S. organization apply if the project includes a foreign component?
No. Non-domestic components of U.S. organizations are not eligible. The applicant organization must be domestic, and grant-supported institutional training activities must not be run through a foreign component.
What is the funding activity category for this opportunity?
The funding activity category listed is Health.
What is the Assistance Listing (CFDA) number associated with this opportunity?
The listed CFDA (now commonly referenced as the Assistance Listing) number is 93.350.
When was this funding opportunity created?
The opportunity was created on 2021-09-22.
What is the original closing date listed for this opportunity?
The original closing date provided is 2024-09-13.
Is an award ceiling provided in the information above?
No. The source information provided does not specify an award ceiling.
Does the information above state how many awards NIH expects to make?
No. The source information provided does not specify the expected number of awards.
Where should applicants look for details on budget structure, trainee slots, and allowable costs?
The information provided indicates that applicants would need to consult the full Funding Opportunity Announcement (FOA) for budget structure details, award limits (if any), and program-specific expectations such as trainee slots, training duration, and allowable costs under the NRSA T32 mechanism.
How should this opportunity be understood at a high level?
It is best understood as a targeted, CTSA-aligned T32 program intended to build institutional capacity for high-quality postdoctoral training in clinical and translational science, emphasizing broad participation and workforce heterogeneity, while maintaining the restriction that supported activities cannot include clinical trials.
Browse more opportunities from the same category: Health
Next opportunity: OVW Fiscal Year 2022 Support for Tribes Exercising Special Domestic Violence Criminal Jurisdiction Initiative Invitation to Apply
Previous opportunity: Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 338
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 338) also looked into and applied for these:
| Funding Opportunity |
|---|
| NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed) Apply for PAR 22 021 Funding Number: PAR 22 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed) Apply for RFA AI 21 065 Funding Number: RFA AI 21 065 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) Apply for PAR 21 326 Funding Number: PAR 21 326 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed) Apply for PAR 21 351 Funding Number: PAR 21 351 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed) Apply for PAR 22 037 Funding Number: PAR 22 037 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed) Apply for PAR 21 312 Funding Number: PAR 21 312 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| SPARC Human Open Research Neural Engineering Technologies (HORNET) Initiative (U41 Clinical Trial Not Allowed) Apply for RFA RM 21 024 Funding Number: RFA RM 21 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neurosurgeon Research Career Development Program (NRCDP) (K12 Independent Clinical Trial Not Allowed) Apply for RFA NS 21 019 Funding Number: RFA NS 21 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) Apply for PAR 22 025 Funding Number: PAR 22 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) Apply for RFA GM 22 001 Funding Number: RFA GM 22 001 Agency: National Institutes of Health Category: Health Funding Amount: $252,000 |
| Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) Apply for RFA MH 22 120 Funding Number: RFA MH 22 120 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) Apply for PAR 22 034 Funding Number: PAR 22 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Apply for PAR 21 321 Funding Number: PAR 21 321 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for PAR 22 048 Funding Number: PAR 22 048 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) Apply for PAR 22 039 Funding Number: PAR 22 039 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) Apply for PAR 22 040 Funding Number: PAR 22 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) Apply for PAR 22 038 Funding Number: PAR 22 038 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 070 Funding Number: RFA AI 21 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional) Apply for RFA MH 22 105 Funding Number: RFA MH 22 105 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Digital Health Strengthening in Eswatini Apply for RFI67421ESWATINIHEALTHINFORMATIONSYSTEM Funding Number: RFI67421ESWATINIHEALTHINFORMATIONSYSTEM Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 338", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.